SCHEMBL31024641

CC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(N)=O

nearest known ligand 0.57

Predicted protein targets (top 14)

	gene	UniProt	supporting neighbours	confidence
▸	SIRT6	Q8N6T7	1/20	0.57

▸	SIRT1	Q96EB6	1/20	0.57

▸	SIRT5	Q9NXA8	2/20	0.55

▸	NPY4R	P50391	10/20	0.47

▸	NPY1R	P25929	7/20	0.47

▸	NPY2R	P49146	6/20	0.47

▸	NPY5R	Q15761	6/20	0.47

▸	TLR2	O60603	2/20	0.46

▸	CA1	P00915	2/20	0.44

▸	CA2	P00918	2/20	0.44

▸	ROCK2	O75116	2/20	0.43

▸	PRKACA	P17612	1/20	0.43

▸	AKT3	Q9Y243	1/20	0.43

▸	ALB	P02768	1/20	0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29626768	1.00	SIRT6 (0.57)	SIRT6SIRT1SIRT5NPY4RNPY1R
SCHEMBL15987249	0.93	SIRT5 (0.57)	SIRT6SIRT1SIRT5NPY4RNPY1R
SCHEMBL16045801	0.93	SIRT5 (0.57)	SIRT6SIRT1SIRT5NPY4RNPY1R
SCHEMBL29397145	0.91	SIRT6 (0.56)	SIRT6SIRT1SIRT5NPY4RNPY1R
SCHEMBL29396582	0.91	SIRT6 (0.56)	SIRT6SIRT1SIRT5NPY4RNPY1R
SCHEMBL29396719	0.91	SIRT6 (0.56)	SIRT6SIRT1SIRT5NPY4RNPY1R
SCHEMBL23335231	0.89	SIRT6 (0.47)	SIRT6SIRT1SIRT5NPY4RNPY1R
SCHEMBL15185942	0.89	NPY4R (0.56)	SIRT6SIRT1NPY4RNPY1RNPY2R
SCHEMBL10169080	0.88	NPY4R (0.54)	SIRT6SIRT1NPY4RNPY1RNPY2R
SCHEMBL24900018	0.88	SIRT5 (0.49)	SIRT6SIRT1SIRT5NPY4RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4665754-A1	GLYCOSYLATED POLYPEPTIDES	Eli Lilly and Company (US)	2025-12-24	—	—	EP	disclosed
WO-2024173266-A1	GLYCOSYLATED POLYPEPTIDES	ELI LILLY AND COMPANY (US)	2024-08-22	—	—	WO	disclosed